When people eat, they ingest the nucleic acids that reside in all living things. The compounds in these acids could inhibit ...

By sensing viral nucleic acids and producing type I interferons, plasmacytoid dendritic cells (pDCs) are key mediators of antiviral immunity. But pDCs might also contribute to autoimmune disease ...

All the latest science news on nucleic acids from Phys.org. Find the latest news, advancements, and breakthroughs.

The global nucleic acid therapeutics CDMO market size is expected to reach USD 33.86 billion by 2030, registering a CAGR of 14.1% during the forecast period.

The companies will leverage and build upon EnviroLogix’ isothermal DNAble® v2.0 chemistry and Douglas Scientific’s Array Tape™ platform.

The nucleic acid molecules inherited by the living cell bear the plan of all the cell's protein molecules. It now appears that another kind of nucleic acid plays a key role in translating the plan ...

Nucleic acid therapeutics, which involve transferring exogenous genes inside target cells, are a promising clinical treatment option that can regulate gene expression at the transcriptional or ...

Nucleic acid technology came of age during COVID-19 with biopharma firms developing, testing, mass producing, and shipping mRNA vaccines in record time. However, as the pandemic ebbs, the industry ...

This article describes the receptors and signalling pathways that are involved in sensing nucleic acids and discusses the implications for current and future vaccination strategies.

Spherical nucleic acids set stage for new paradigm in drug development Date: March 16, 2015 Source: Northwestern University Summary: Spherical nucleic acids (SNAs) can be used as potent drugs to ...

When people eat, they ingest the nucleic acids that reside in all living things. The compounds in these acids could inhibit the growth of cancer cells, according to findings published in PLOS ONE by ...

Advanced smart nanoparticles enhance the delivery of nucleic acid therapeutics to cancer cells, addressing many of the barriers that have hindered their clinical applications, according to a ...